1. Home
  2. WVVI vs NERV Comparison

WVVI vs NERV Comparison

Compare WVVI & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Willamette Valley Vineyards Inc.

WVVI

Willamette Valley Vineyards Inc.

HOLD

Current Price

$2.91

Market Cap

13.0M

ML Signal

HOLD

Logo Minerva Neurosciences Inc

NERV

Minerva Neurosciences Inc

HOLD

Current Price

$3.98

Market Cap

14.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WVVI
NERV
Founded
1983
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.0M
14.6M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
WVVI
NERV
Price
$2.91
$3.98
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
$4.00
AVG Volume (30 Days)
8.7K
71.2K
Earning Date
11-13-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$37,366,837.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.49
$1.15
52 Week High
$7.18
$12.46

Technical Indicators

Market Signals
Indicator
WVVI
NERV
Relative Strength Index (RSI) 51.28 52.59
Support Level $2.71 $3.51
Resistance Level $3.00 $4.21
Average True Range (ATR) 0.15 0.33
MACD 0.07 -0.02
Stochastic Oscillator 88.00 60.35

Price Performance

Historical Comparison
WVVI
NERV

About WVVI Willamette Valley Vineyards Inc.

Willamette Valley Vineyards Inc produces and sells premium, super-premium, and ultra-premium wines. The grapes are harvested, fermented, and made into wine at the company's Turner winery, and the wines are sold principally under its Willamette Valley Vineyards label and also under the Griffin Creek, Tualatin Estate, Pambrun, Maison Bleue, Natoma, Metis, and Elton labels. It operates under two operating segments, direct sales and distributor sales. Direct sales include retail sales in its tasting room and remote sites, wine club sales, online sales, on-site events, kitchen and catering sales, and other sales made directly to the consumer without the use of an intermediary. Distributor sales include all sales through a third party where prices are given at a wholesale rate.

About NERV Minerva Neurosciences Inc

Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.

Share on Social Networks: